188 related articles for article (PubMed ID: 7652766)
1. Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
Fung-Leung WP; Pope BL; Chourmouzis E; Panakos JA; Lau CY
Transplantation; 1995 Aug; 60(4):362-8. PubMed ID: 7652766
[TBL] [Abstract][Full Text] [Related]
2. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
3. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Yuh DD; Morris RE
Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.
Wolos JA; Frondorf KA; Babcock GF; Stripp SA; Bowlin TL
Cell Immunol; 1993 Jul; 149(2):402-8. PubMed ID: 8330316
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine combined with nonlytic interleukin 2/Fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model.
Li Z; Zhang D; Gao J; Li WX; Zhu JY
Transplant Proc; 2013; 45(6):2559-64. PubMed ID: 23953581
[TBL] [Abstract][Full Text] [Related]
7. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of Transplantation.
Ellis JD; Neil DA; Inston NG; Jenkinson E; Drayson MT; Hampson P; Shuttleworth SJ; Ready AR; Cobbold M
Transplantation; 2016 Aug; 100(8):1667-74. PubMed ID: 27222932
[TBL] [Abstract][Full Text] [Related]
9. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A.
Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395
[TBL] [Abstract][Full Text] [Related]
10. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
Levite M; Reisner Y
Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
12. Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.
Kazmi SM; Plante RK; Visconti V; Taylor GR; Zhou L; Lau CY
J Cell Biochem; 1995 Feb; 57(2):299-310. PubMed ID: 7759567
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
Rayat G; Yatscoff R; Silverman R; McKenna R
Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
[TBL] [Abstract][Full Text] [Related]
14. Tepoxalin blocks neutrophil migration into cutaneous inflammatory sites by inhibiting Mac-1 and E-selectin expression.
Zhou L; Pope BL; Chourmouzis E; Fung-Leung WP; Lau CY
Eur J Immunol; 1996 Jan; 26(1):120-9. PubMed ID: 8566054
[TBL] [Abstract][Full Text] [Related]
15. Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation.
Kalnins A; Thomas MN; Andrassy M; Müller S; Wagner A; Pratschke S; Rentsch M; Klussmann S; Kauke T; Angele MK; Bazhin AV; Fischereder M; Werner J; Guba M; Andrassy J
Scand J Immunol; 2015 Aug; 82(2):102-9. PubMed ID: 25970072
[TBL] [Abstract][Full Text] [Related]
16. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
17. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice.
Veyron P; Pamphile R; Binderup L; Touraine JL
Transpl Immunol; 1993; 1(1):72-6. PubMed ID: 8081764
[TBL] [Abstract][Full Text] [Related]
18. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
Malm H; Corbascio M; Osterholm C; Cowan S; Larsen CP; Pearson TC; Ekberg H
Transplantation; 2002 Jan; 73(2):293-7. PubMed ID: 11821746
[TBL] [Abstract][Full Text] [Related]
19. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
